Julie Nye

Julie Nye has a diverse work experience in the biotechnology industry. Julie began their career at Onyx Pharmaceuticals in 1993, where they worked as a Senior Research Associate until 2000. During this time, they focused on constructing and writing patents for Ad5 anti-tumor shuttle vectors, testing gene expression, and conducting mutagenesis analysis.

From 2007 to 2008, Julie worked as an Associate Scientist at Novartis on a temporary basis. Julie'sresponsibilities included performing target stratification for novel protein therapeutics and conducting cell proliferation assays.

In 2009, Julie held another temporary position as an Associate Scientist at Novartis. Julie continued to perform target stratification and cell proliferation assays in this role.

From 2009 to 2010, Julie worked as a Senior Research Associate on a temporary basis at Bayer HealthCare. Julie conducted research and supported project initiatives during their time at the company.

In 2010, Julie worked as a Senior Research Associate on a temporary basis at XOMA. Julie provided research support and conducted cell-based assays for preclinical therapeutic groups.

From 2011 to 2011, Julie held a temporary position as a Research Associate III at XOMA. Julie developed and implemented cell-based assays to test antibody candidates for metabolic and cancer-related diseases.

Julie joined Catalyst Biosciences in 2012 and worked as a Research Associate until 2014. Julie'sresponsibilities during this time included conducting research in the field of biotechnology.

Lastly, Julie's most recent position was at 4D Molecular Therapeutics. Julie started in 2015 and held the role of Senior Research Associate II. Julie'sresponsibilities in this role included conducting research in the field of molecular therapeutics.

Julie Nye has obtained a Bachelor of Science (B.S.) degree in General Science/Biology and a Bachelor of Science (B.S.) degree in Biology, General from the University of Oregon. The specific years of their education are not provided.